$0.54
-0.04 (-7.55%)
Open$0.57
Previous Close$0.58
Day High$0.58
Day Low$0.51
52W High$2.62
52W Low$0.73
Volume—
Avg Volume2.02M
Market Cap115.71M
P/E Ratio—
EPS$-1.03
SectorBiotechnology
Analyst Ratings
Strong Buy
12 analysts
Price Target
+6,622.4% upside
Current
$0.54
$0.54
Target
$36.20
$36.20
$24.75
$36.20 avg
$54.95
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 55.12M | 94.27M | 45.49M |
| Net Income | 219.61M | 338.03M | -11,017,037 |
| Profit Margin | 398.4% | 378.5% | -24.2% |
| EBITDA | -231,625,895 | -376,337,609 | -13,211,435 |
| Free Cash Flow | — | — | -11,236,120 |
| Rev Growth | -41.5% | -41.5% | +9.2% |
| Debt/Equity | 0.84 | 0.84 | 0.72 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.45 | -0.18% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $467.06 | -0.22% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $167.95 | -1.05% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $542.62 | -0.81% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $951.19 | -0.86% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.65 | -2.00% | 7.7 | 20.98B |